Toll Free: 1-888-928-9744

Follicular Lymphoma Global Clinical Trials Review, H1, 2016

Published: May 31, 2016 | Pages: 775 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Follicular Lymphoma Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Follicular Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Follicular Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Follicular Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12 Top Five Countries Contributing to Clinical Trials in Central and South America 13 Clinical Trials by G7 Countries: Proportion of Follicular Lymphoma to Oncology Clinical Trials 14 Clinical Trials by Phase in G7 Countries 15 Clinical Trials in G7 Countries by Trial Status 16 Clinical Trials by E7 Countries: Proportion of Follicular Lymphoma to Oncology Clinical Trials 17 Clinical Trials by Phase in E7 Countries 18 Clinical Trials in E7 Countries by Trial Status 19 Clinical Trials by Phase 20 In Progress Trials by Phase 21 Clinical Trials by Trial Status 22 Clinical Trials by End Point Status 23 Subjects Recruited Over a Period of Time 24 Clinical Trials by Sponsor Type 25 Prominent Sponsors 26 Top Companies Participating in Follicular Lymphoma Therapeutics Clinical Trials 27 Prominent Drugs 28 Latest Clinical Trials News on Follicular Lymphoma 29 May 18, 2016: AbbVie To Present Data on Duvelisib at ASCO 2016 29 May 12, 2016: Epizyme to Present Data From the Tazemetostat Non-Hodgkin Lymphoma Program at American Society for Hematology Meeting on Lymphoma Biology 29 Mar 17, 2016: Information Update - International clinical trials, including trials in Canada, are being stopped due to serious adverse events with the drug Zydelig, in combination with other cancer drugs 30 Mar 09, 2016: Genmab Achieves Second Milestone in Daratumumab NHL Study Under Collaboration with Janssen 30 Feb 25, 2016: Seattle Genetics Initiates Phase I Trial of SGN-CD19B for Patients with B-cell Non-Hodgkin Lymphoma 31 Clinical Trial Profile Snapshots 32 Appendix 772 Abbreviations 772 Definitions 772 Research Methodology 773 Secondary Research 773 About GlobalData 774 Contact Us 774 Disclaimer 774 Source 775
List of Tables
Follicular Lymphoma Therapeutics, Global, Clinical Trials by Region, 2016* 6 Follicular Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Follicular Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Follicular Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9 Follicular Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10 Follicular Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2016* 11 Follicular Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12 Follicular Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13 Proportion of Follicular Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2016* 14 Follicular Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Follicular Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Follicular Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2016* 17 Follicular Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 Follicular Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 Follicular Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2016* 20 Follicular Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21 Follicular Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 Follicular Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 Follicular Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 Follicular Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25 Follicular Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 Follicular Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 Follicular Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28


List of Figures
Follicular Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Follicular Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Follicular Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Follicular Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9 Follicular Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10 Follicular Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11 Follicular Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12 Follicular Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13 Proportion of Follicular Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2016* 14 Follicular Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Follicular Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Follicular Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2016* 17 Follicular Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 Follicular Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 Follicular Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20 Follicular Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21 Follicular Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 Follicular Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 Follicular Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 Follicular Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25 Follicular Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 Follicular Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 Follicular Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28 GlobalData Methodology 773

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global integrated systems market is projected to reach USD 24 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to re-evaluate data center infrastructure is expected to boost the demand. Change in trend from main

Read More...

Global sorbitol market size is anticipated to be reach USD 3.99 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing consumer perception towards product benefits derived from natural ingredients is expected to drive the dem

Read More...

Global heat transfer fluids market size is likely to be valued at USD 3.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing demand for for heat recovery management in industries such as metal processing, pharmaceutica

Read More...

Global alpha olefins market size is likely to be valued at USD 10.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing polyethylene demand for use in plastic production is anticipated to drive market growth. Growing ap

Read More...

Global gas sensors market is expected to reach USD 2,512.4 million by 2020, as per a new research report by Radiant Insights, Inc. High adoption rate of wireless and smart gas sensor technology coupled with escalating demand from end-use industries s

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify